Task: Answer the multiple choice question.
Query: Which compound exhibits a -4.750% hERG inhibition at 10uM?
Constraint: You must select none, one or more options from a, b, or c without using any other words.
Options:
a Cc1cc(C)nc(SCC(=O)N/N=C/c2cccn2-c2cccc(C(F)(F)F)c2)n1
b COCC1CCN(C(=O)CCc2nnc(CCCCc3ccccc3)o2)CC1
c CCOC(=O)c1c2n(c3ccc(O)cc13)CCCCC2
Answer: b. COCC1CCN(C(=O)CCc2nnc(CCCCc3ccccc3)o2)CC1
{#Task|Problem statement!}: Answer the {#multiple choice|multiple-choice|MCQ!} question.
{#Question|Query!}: Which {#compound|drug!} {#has|exhibits!} a {herg_central_at_10uM#}{herg_central_at_10uM__units} {herg_central_at_10uM__names__noun}?
Constraint: You must select none, one or more options from {%multiple_choice_enum%2-5%aA1} without using any {#other|additional!} words.
Options:
{SMILES%herg_central_at_10uM%}
Answer: {%multiple_choice_result}. {SMILES#}
COCC1CCN(C(=O)CCc2nnc(CCCCc3ccccc3)o2)CC1
COCC1CCN(C(=O)CCc2nnc(CCCCc3ccccc3)o2)CC1
1-[4-(methoxymethyl)piperidin-1-yl]-3-[5-(4-phenylbutyl)-1,3,4-oxadiazol-2-yl]propan-1-one